Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults with locally advanced or metastatic RET fusion-positive solid tumors progressing on or after prior systemic treatment or without satisfactory alternatives.
LAMPGEN ANALYSIS
Why it matters
The action extends RET-directed treatment beyond lung and thyroid cancer to a molecularly selected solid tumor population.
What research teams should watch
Verify a RET fusion, tumor extent, and therapy history rather than relying on a generic RET alteration field.
PRIMARY RECORDS